Published in Breast on March 26, 2007
Prevalence of specific language impairment in kindergarten children. J Speech Lang Hear Res (1997) 6.37
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Characteristics of firearms involved in fatalities. JAMA (1996) 3.95
Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron. J Bacteriol (1980) 3.54
Interspersed requests: a nonaversive procedure for reducing aggression and self-injury during instruction. J Appl Behav Anal (1991) 3.03
Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet (1980) 2.82
Nucleolar localization of early tRNA processing. Genes Dev (1998) 2.78
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77
Loss of consciousness and post-traumatic stress disorder. A clue to aetiology and treatment. Br J Psychiatry (1998) 2.76
Underprediction of human skin erythema at low doses per fraction by the linear quadratic model. Radiother Oncol (1996) 2.69
Endoscopic guided percutaneous tracheostomy: early results of a consecutive trial. J Trauma (1990) 2.64
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Platinum-based chemotherapy in triple-negative breast cancer. Ann Oncol (2008) 2.46
Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol (2006) 2.40
Some methodological problems in studying consultations in general practice. J R Coll Gen Pract (1976) 2.33
Production of an S RNase with dual specificity suggests a novel hypothesis for the generation of new S alleles. Plant Cell (1999) 2.28
Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J Virol (2000) 2.24
A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res (1997) 2.13
Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst (2001) 2.13
A colony-forming assay for human tumour xenografts using agar in diffusion chambers. Br J Cancer (1976) 2.11
Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology (1998) 2.11
Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab (1996) 2.06
Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res (1995) 2.05
Social class variations in health care and in the nature of general practitioner consultations. Sociol Rev Monogr (1976) 2.03
Low dose rate teletherapy and tumour response. Australas Radiol (1993) 1.94
Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer. Br J Cancer (2004) 1.87
Assessment methods for alcohol consumption, prevalence of high risk drinking and harm: a sensitivity analysis. Int J Epidemiol (1999) 1.84
Delay in the diagnosis of pediatric brain tumors. Am J Dis Child (1986) 1.83
Psychiatric morbidity among adults living in private households, 2000. Int Rev Psychiatry (2004) 1.81
Enzymatic profile of Pseudomonas maltophilia. J Clin Microbiol (1982) 1.73
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer (2004) 1.69
Palliative chemotherapy for advanced non-small cell lung cancer. BMJ (1994) 1.67
Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol (1991) 1.66
Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis. Eur J Cancer (2001) 1.65
Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ (2003) 1.60
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Ann Oncol (2005) 1.58
Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med (1992) 1.58
Part-time training: experience in the Northern Region. Public Health (1984) 1.55
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br J Psychiatry (2004) 1.54
A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg (1997) 1.54
Endoscopic band ligation of bleeding dieulafoy lesions: the best therapeutic strategy. Endoscopy (2006) 1.53
The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol (1986) 1.52
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group. Eur J Cancer (1997) 1.52
Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol (1987) 1.51
Colonization of the gut of the blue crab (Callinectes sapidus) by Vibrio cholerae. Appl Environ Microbiol (1986) 1.50
Breast cancer in adolescents and young women. Eur J Cancer (2003) 1.49
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration. Lancet (1994) 1.49
Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes (1996) 1.49
Changes in health-related quality of life following coronary artery bypass graft surgery. Ann Thorac Surg (2001) 1.48
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol (1995) 1.48
Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer (2005) 1.48
Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancer. Lancet (1995) 1.47
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer. J Clin Oncol (1987) 1.47
Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma. Cancer (1995) 1.47
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
How much blame can be placed on laser photocoagulation for failure to attain driving standards? Eye (Lond) (1995) 1.44
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter? Br J Cancer (2009) 1.44
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience. Ann Oncol (2012) 1.44
Low-risk drinking guidelines: the scientific evidence. Can J Public Health (1999) 1.43
Intra-articular morphine for pain relief after anterior cruciate ligament repair. Br J Anaesth (1993) 1.41
Influence of HLA matching and associated factors on aortic valve homograft function. J Heart Valve Dis (2000) 1.41
New treatments for advanced cancer: an approach to prioritization. Br J Cancer (2000) 1.41
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women. J Clin Endocrinol Metab (1993) 1.41
Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol (2009) 1.40
Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Res Treat (1998) 1.39
Mitomycin C, vinblastine and carboplatin: effective outpatient chemotherapy for advanced non-small cell carcinoma of the lung (NSCLC). Clin Oncol (R Coll Radiol) (2001) 1.39
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma. Lancet (1980) 1.38
Effects of prenatal alcohol exposure at school age. I. Physical and cognitive development. Neurotoxicol Teratol (1991) 1.37
Utilization of xylan by two species of human colonic Bacteroides. Appl Environ Microbiol (1981) 1.36
Home and hospital: a comparison of the experiences of mothers having home and hospital confinements. J R Coll Gen Pract (1978) 1.36
Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J (2000) 1.36
Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer. Eur J Cancer Clin Oncol (1984) 1.34
NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol (2000) 1.34
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone. Oncogene (2000) 1.34
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Br Med J (Clin Res Ed) (1981) 1.33
Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Clin Cancer Res (1999) 1.32
A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation (1992) 1.32
Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) (1994) 1.32
Postmortem whole-body magnetic resonance imaging as an adjunct to autopsy: preliminary clinical experience. J Magn Reson Imaging (2001) 1.32
Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet (1997) 1.31
In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res (1978) 1.31
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. Br J Cancer (1995) 1.29
Relationship between the developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes. Dev Biol (1994) 1.28
Role of the lactate transporter (MCT1) in skeletal muscles. Am J Physiol (1996) 1.28
Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg Med Chem Lett (1998) 1.27
Criteria for the diagnosis of sinus mycetoma. J Allergy Clin Immunol (1997) 1.27
Transformation to "high grade" neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma. Lung Cancer (2013) 1.27
Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet (1978) 1.27
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed (1998) 1.27
The role of the lumbar facet joints in spinal stability. Identification of alternative paths of loading. Spine (Phila Pa 1976) (1994) 1.25
Defective zonae pellucidae in Zp2-null mice disrupt folliculogenesis, fertility and development. Development (2001) 1.25
Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer. J Clin Endocrinol Metab (1982) 1.25
Questionnaire-based measures are valid for the identification of rural households with hunger and food insecurity. J Nutr (1997) 1.25